Aceng noted that GAVI, the Vaccines Alliance has put aside funding to support local manufacture of vaccines in Africa but so far, no Ugandan company has picked interest and yet countries like South Africa, Senegal and Rwanda are already benefitting.
Michael Kamya, who heads the Microbiology Lab at Lancet Laboratories Uganda, says while they have the personnel who can conduct the tests, they would require some training from the Health Ministry if they are to conduct the tests.
The scheme which will help private healthcare practitioners access credit is expected to start in July next year as they still await contributions from donors and contributing commercial banks.
